Shanghai, China

Xiong Wei

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Shanghai Yao Yuan Biotechnology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiong Wei. Retrieved from https://idiyas.com/inventor/xiong-wei-py4f7mil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 11.0


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xiong Wei: Innovator in Kawasaki Disease Treatment

Introduction: Xiong Wei is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the treatment of Kawasaki disease. His innovative approach has led to the development of a unique patent that addresses this serious condition.

Latest Patents: Xiong Wei holds a patent for "Alpha protein kinase 1 inhibitors for use in treating Kawasaki disease." This patent outlines methods for inhibiting ALPK1 kinase activity using a compound of Formula I. The compositions and methods described in the patent are aimed at providing therapeutic solutions for Kawasaki disease.

Career Highlights: Xiong Wei is associated with Shanghai Yao Yuan Biotechnology Co., Ltd., where he applies his expertise in biotechnology to advance medical treatments. His work has garnered attention for its potential impact on patient care and treatment options.

Collaborations: Xiong Wei collaborates with talented individuals in his field, including coworkers Yuning Wei and Danyang Liu. Their combined efforts contribute to the innovative research and development at their company.

Conclusion: Xiong Wei's contributions to the treatment of Kawasaki disease through his patent and work at Shanghai Yao Yuan Biotechnology Co., Ltd. highlight his role as a key innovator in the biotechnology sector. His dedication to advancing medical science is commendable and has the potential to improve the lives of many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…